NONALCOHOLIC FATTY LIVER DISEASE
Clinical trials for NONALCOHOLIC FATTY LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new NONALCOHOLIC FATTY LIVER DISEASE trials appear
Sign up with your email to follow new studies for NONALCOHOLIC FATTY LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for reversing fatty liver damage in major trial
Disease control CompletedThis study tested a new medicine called efinopegdutide in 381 adults with nonalcoholic steatohepatitis (NASH), a serious fatty liver disease that can lead to cirrhosis. The main goal was to see if the drug could reverse signs of liver inflammation without making scarring worse. R…
Matched conditions: NONALCOHOLIC FATTY LIVER DISEASE
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Can vitamin e tame fatty liver? new study tests best dose
Disease control CompletedThis study looked at whether vitamin E can help adults with nonalcoholic fatty liver disease (NAFLD). Researchers tested different doses in 200 people to see which one best lowered liver enzyme levels. The goal was to find a safe and effective dose for controlling the disease.
Matched conditions: NONALCOHOLIC FATTY LIVER DISEASE
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated May 11, 2026 20:39 UTC